LARITZA LINCHETA ENRIQUEZ: Open Payments
NPI 1033740287 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 15 payments from 12 companies in 2025. Trend: 2023 $2,155 · 2024 $2,652 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $167 |
| HEARTFLOW, INC. | 1 | $146 |
| Gilead Sciences, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Intercept Pharmaceuticals, Inc. | 1 | $28 |
| Celltrion USA Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| EVOKE PHARMA, INC. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $22 |
Products named: FFRct, CREON, Livdelzi, Wegovy, LINZESS, XIFAXAN, OCALIVA, VEGZELMA.
Industry payments across FL — which companies pay providers there.
